Log in to save to my catalogue

Increases in Serum TARC/CCL17 Levels Are Associated with Progression-Free Survival in Advanced Melan...

Increases in Serum TARC/CCL17 Levels Are Associated with Progression-Free Survival in Advanced Melan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733969387

Increases in Serum TARC/CCL17 Levels Are Associated with Progression-Free Survival in Advanced Melanoma Patients in Response to Dendritic Cell-Based Immunotherapy

About this item

Full title

Increases in Serum TARC/CCL17 Levels Are Associated with Progression-Free Survival in Advanced Melanoma Patients in Response to Dendritic Cell-Based Immunotherapy

Publisher

Boston: Boston : Springer US

Journal title

Journal of clinical immunology, 2009-09, Vol.29 (5), p.657-664

Language

English

Formats

Publication information

Publisher

Boston: Boston : Springer US

More information

Scope and Contents

Contents

Introduction Changes in the levels of serum cytokines and growth factors are associated with response to therapy. We examined cytokine, chemokine, and growth factor levels in serum collected from normal volunteers or metastatic melanoma patients receiving dendritic cell-based immunotherapy. Materials and Methods Using an array for 42 cytokines, che...

Alternative Titles

Full title

Increases in Serum TARC/CCL17 Levels Are Associated with Progression-Free Survival in Advanced Melanoma Patients in Response to Dendritic Cell-Based Immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_733969387

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733969387

Other Identifiers

ISSN

0271-9142

E-ISSN

1573-2592

DOI

10.1007/s10875-009-9299-3

How to access this item